| 四川科伦博泰生物医药股份有限公司 - H股, 06990.HK - 财务比率 |
2022-12 |
2021-12 |
| 变现能力分析 |
| 流动比率(倍) |
0.08 |
0.09 |
| 速动比率(倍) |
0.07 |
0.06 |
| 偿债能力分析 |
| 长期债项/股东权益(%) |
-1.28 |
-0.05 |
| 总债项/股东权益(%) |
-93.43 |
-90.43 |
| 总债项/资本运用(%) |
-94.96 |
-90.84 |
| 投资回报分析 |
| 股东权益回报率(%) |
16.99 |
31.11 |
| 资本运用回报率(%) |
17.27 |
31.25 |
| 总资产回报率(%) |
0.0 |
0.0 |
| 盈利能力分析 |
| 经营利润率(%) |
0.0 |
0.0 |
| 税前利润率(%) |
0.0 |
0.0 |
| 边际利润率(%) |
0.0 |
0.0 |
| 营运能力分析 |
| 存货周转率(倍) |
15.27 |
0.41 |
| 投资收益分析 |
| 派息比率(%) |
0.0 |
0.0 |
| 相关统计 |
| 财政年度周最高价 |
0.0 |
0.0 |
| 财政年度周最低价 |
0.0 |
0.0 |
| 财政年度最高市盈率(倍) |
0.0 |
0.0 |
| 财政年度最低市盈率(倍) |
0.0 |
0.0 |
| 财政年度最高周息率(%) |
0.0 |
0.0 |
| 财政年度最低周息率(%) |
0.0 |
0.0 |
|
We've noticed you're using an ad blocker
We spend millions of dollars each year so you can access, for FREE, the highest quality real-time quotes and charts. This is made possible only thanks to the advertising on our site.
To continue using 88iv.com, please allow this domain on your ad blocker.
We are thanksful for your decisive action.
This notice will be shown again every hour.
Close This Window